首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Exploration of pyridine containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors
Authors:Motiwala Hashim  Kandre Shivaji  Birar Vishal  Kadam Kishorkumar S  Rodge Atish  Jadhav Ravindra D  Mahesh Kumar Reddy M  Brahma Manoja K  Deshmukh Nitin J  Dixit Amol  Doshi Lalit  Gupte Amol  Gangopadhyay Ashok K  Vishwakarma Ram A  Srinivasan Shaila  Sharma Mamta  Nemmani Kumar V S  Sharma Rajiv
Institution:Department of Medicinal Chemistry, Piramal Life Sciences Limited, Goregaon (E), Mumbai 400 063, Maharashtra, India.
Abstract:The diacylglycerol acyltransferase enzyme, DGAT1, presents itself as a potential target for obesity as this enzyme is dedicated to the final committed step in triglyceride biosynthesis. Biphenyl ureas, exemplified by compound 4, have been reported to be potent hDGAT1 inhibitors. We have synthesized and evaluated 2-pyridyl and 3-pyridyl containing biaryl ureas as hDGAT1 inhibitors. Our aim was to incorporate a heteroaryl scaffold within these molecules thereby improving the cLogP profile and making these compounds more drug-like. Compounds within this series exhibited potent hDGAT1 inhibition when evaluated using an in vitro enzymatic assay. Selected compounds were also subjected to an oral fat tolerance test in mice where the percent triglyceride reduction versus a vehicle control was evaluated. Of the studied heteroaryl analogs compound 44 exhibited an in vitro IC(50) of 17nM and a plasma triglyceride reduction of 79% along with a 12-fold improvement in solubility over the biphenyl urea compound 4.
Keywords:Diacylglycerol acyltransferase (DGAT)  Obesity  Triglycerides  Fat tolerance test (FTT)
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号